Antibiotic resistance, the ability of bacteria to withstand antimicrobial treatment, poses a significant and escalating global threat.  Its implications are far-reaching, impacting healthcare systems, economies, and global security.  The review of current literature reveals a concerning rise in resistant infections, rendering previously effective treatments obsolete and increasing morbidity and mortality rates.  This resistance stems from various factors, including the overuse and misuse of antibiotics in both human and animal healthcare, coupled with a lack of robust infection control practices.

The consequences extend beyond individual health; increased treatment costs, prolonged hospital stays, and reduced productivity significantly burden healthcare systems worldwide. The lack of new antibiotic development further exacerbates the issue.  Practical applications focus on several key areas: improved stewardship programs promoting judicious antibiotic use, enhanced infection prevention and control measures, the development of rapid diagnostic tools enabling targeted treatment, and intensified research into novel antimicrobial agents and alternative therapeutic strategies, such as phage therapy and immunotherapies.  Addressing this global challenge requires a multi-faceted, coordinated approach encompassing global collaboration, policy changes, and increased public awareness to mitigate the devastating impact of antibiotic resistance.